- [CIRUGÍA GENERAL Y DIGESTIVA]
- [ONCOLOGÍA MÉDICA]
- [CIRUGÍA TORÁCICA]
- [ANATOMÍA PATOLÓGICA]
- [ÁREA DE TUMORES DIGESTIVOS]
Transthoracic oesophagectomy with lymphadenectomy in 100 oesophageal cancer patients. Multidisciplinary approach
Valentí V, Hernández-Lizoain JL, Martínez-Regueira F, Bellver M, Rodríguez J, Díaz González JA, Torre W, Sola JJ, Alvarez-Cienfuegos J.
General Surgery Department, Clínica Universidad de Navarra, University of Navarre, Pamplona, Navarra, Spain.
Analysis of the results on the treatment of esophageal cancer by transthoracic esophagectomy by a multidisciplinary team of surgeons and oncologists.
Between January 1990 and December 2009, 100 consecutive patients underwent transthoracic esophagectomy. Data were collected prospectively and clinical, pathological and histological features of the tumors were analyzed as well as the results of postoperative morbidity and mortality.
The average patient age was 55 years (range 31- 83 years). In 59 cases the tumor was located in the lower third and in 41 cases in the middle third. Forty-six patients had adenocarcinoma and 54 squamous cell carcinoma. In 54 cases radio-chemotherapy was planned preoperatively. Classification according to pathological tumor stage was: stage 0 in 21 patients, stage I in 10 patients, stage IIa in 28, stage IIb in 9, stage III in 21 and stage IV in 11. The mean number of lymph nodes examined was 14 (range 0-28). Hospital mortality occurred in 4 cases and postoperative complications in 29 patients (33%). The most frequent postoperative complication was pulmonary complications in 17 cases. The average hospital stay was 15.2 days (range 10-40 days)
The results of esophageal cancer have been improved in recent years due to the formation of multidisciplinary teams in this pathology. In our study we have shown that the results obtained with the transthoracic technique for cancer of the esophagus are within the ranges reported in the literature for teams with high prevalence of the disease.
CITA DEL ARTÍCULO Clin Transl Oncol. 2011 Dec;13(12):899-903